Inhibikase Therapeutics Cash Flow Statement (2020-2026) | IKT

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-4.47M-5.02M-4.64M-4.64M-4.56M-4.33M-4.76M-6.24M-4.80M-4.40M-4.80M-5.24M-5.98M-12.93M-14.60M-10.87M-12.77M-45.43M-17.84M-21.05M
Depreciation and Depletion (Quarter)
0.00M0.01M0.01M0.16M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M
Share-based Compensation (Quarter)
0.35M0.27M0.12M0.13M0.10M0.10M0.12M0.12M0.13M0.12M0.05M0.03M0.15M7.91M2.04M4.21M4.53M4.53M5.56M5.35M
Gains from Investment Securities (Quarter)
0.18M0.03M
Cash from Operations (Quarter)
-2.02M-4.10M-3.93M-4.36M-5.50M-3.56M-5.97M-4.57M-4.11M-3.44M-3.87M-5.05M-4.88M-5.35M-4.10M-5.57M-10.59M-7.52M-12.06M-12.44M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.00M0.01M0.01M0.16M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
-0.37M-0.11M-0.06M-0.04M0.01M0.14M0.02M0.02M-0.08M
Change in Account Payables (Quarter)
-0.33M0.54M-0.28M0.05M-0.08M0.37M-0.19M-0.20M-0.02M-0.09M0.48M0.40M0.45M-1.06M0.68M0.91M-1.98M0.54M0.43M-0.63M
Change in Accured Expenses (Quarter)
1.03M0.81M0.86M0.03M-1.34M0.13M-0.84M0.27M0.03M0.40M0.25M-0.47M0.13M0.52M0.83M-0.58M0.72M0.42M0.04M5.14M
Other Working Capital Changes (Quarter)
-0.14M-0.34M0.36M-1.00-0.01M0.76M-0.38M-0.17M-0.10M0.01M0.05M-0.06M0.13M0.07M-0.01M-0.59M0.06M-0.36M
Investing Activities
Capital Expenditures (Quarter)
0.20M0.01M
Cash from Investing Activities (Quarter)
-0.04M-20.93M4.96M-5.84M2.55M17.06M-2.12M-3.31M2.54M2.53M-38.76M21.05M9.84M-28.75M-0.10M-80.48M-5.91M
Financing Activities
Other financing activities (Quarter)
0.04M41.06M0.04M0.25M0.56M
Cash from Financing Activities (Quarter)
0.03M-0.20M8.58M-0.04M70.00-0.14M0.37M3.24M0.18M99.68M0.03M-0.13M108.57M2.90M-0.01M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.04M-41.14M1.00M7.54M70.00452.000.40M3.21M0.18M99.68M150.00107.62M2.90M
Additional items
Change in Cash (Quarter)
-1.99M-4.10M-4.14M-4.40M-26.43M1.41M-3.23M-2.05M12.96M-5.70M-6.81M0.73M-2.17M55.58M16.95M4.30M-39.47M100.95M-89.65M-18.37M
Free Cash Flow (Quarter)
-2.02M-4.10M-3.93M-4.36M-5.70M-3.56M-5.97M-4.57M-4.11M-3.44M-3.87M-5.05M-4.88M-5.35M-4.12M-5.57M-10.59M-7.52M-12.06M-12.44M
Net Cash Flow (Quarter)
-1.99M-4.10M-4.14M-4.40M-26.43M1.41M-3.23M-2.05M12.96M-5.70M-6.81M0.73M-2.17M55.58M16.95M4.30M-39.47M100.95M-89.65M-18.37M